RLAY - Relay Therapeutics GAAP EPS of -$0.56 beats by $0.14 revenue of $0.25M beats by $0.08M
- Relay Therapeutics press release ( NASDAQ: RLAY ): Q4 GAAP EPS of -$0.56 beats by $0.14 .
- Revenue of $0.25M (-56.1% Y/Y) beats by $0.08M .
- Approximately $1 billion in cash, cash equivalents and investments at end of 2022, expected to fund operations into 2025
For further details see:
Relay Therapeutics GAAP EPS of -$0.56 beats by $0.14, revenue of $0.25M beats by $0.08M